Direct-to-Consumer Pharmaceutical Marketing 2005: Controversies Continue

    Published: April 1, 2005 | Price: $1,995.00 – $3,990.00

    This timely overview of direct to consumer (DTC) pharmaceutical marketing examines the numerous issues surrounding DTC practices and markets, using industry and consumer publications as well as interviews with industry experts. The topics examined include: DTC marketing spending by product, DTC marketing spending by company DTC marketing spending by media channel The ROI debate on the cost-effectiveness of DTC marketing expenditures Arguments for and against DTC marketing by its proponents and critics DTC marketing regulations in the U.S. and selected...
    Computer-Assisted Surgical Systems: A Market Briefing

    Published: February 1, 2005 | Price: $995.00 – $1,990.00

    Computer-based technologies offer significant potential for improving the clinical outcomes of patients. Computer software and hardware, as well as the systems they control, have begun to impact the manner in which surgeons design, plan, simulate and perform surgery. In the last few years, automated and computer-assisted techniques have found increased use in surgical procedures as tools for performing difficult neurosurgery, cranio-facial surgery and some orthopedic procedures. These techniques give the surgeon more advanced capabilities than were available previously, such as...
    Neurological Catheters: A Market Briefing

    Published: February 1, 2005 | Price: $995.00 – $1,990.00

    Neurological catheters, also known as microcatheters, are small devices that can navigate the intricate intracranial vasculature of the brain. These catheters--some on the market, others in development--are used for a variety of applications, including aneurysm occlusion, chronic pain relief, targeted drug delivery, tumor embolization, treating vascular malformations, brachytherapy, and vasospasm therapy. They also promise to be extremely useful in the delivery of therapeutic genes or stem cells to patients who may have a variety of neurological diseases. This report analyzes...
    The Worldwide Market for Cancer Therapeutics

    Published: February 1, 2005 | Price: $3,500.00 – $7,000.00

    The world market for cancer therapeutics is growing at a brisk double-digit pace, with revenues surpassing $40 billion this year. This study looks at each therapeutic approach in turn, reporting and forecasting revenues from 2002 through 2009. Market share by leading competitor in each therapy type is estimated for the year 2004. Therapy types considered, include: Chemotherapy Hormone Therapy Radiation Therapy Immunotherapy and Biotherapy, and Adjunctive Therapies The study focuses on current and emerging markets, products in development, and trends...
    Autism Therapeutics: A Market Briefing

    Published: January 15, 2005 | Price: $995.00 – $1,990.00

    Despite the traditional notion that nothing therapeutic can be accomplished for the 1.5 million Americans with autism and the 2 million more throughout the world, there are pharmacologic approaches to the disease that are providing some help for patients and garnering revenues for drug companies. This Market Briefing reviews the market for drugs used in the treatment of autism and related disorers, including Antidepressants, Anti-Anxiety drugs, Anti-psychotics, Anti-convulsants, and CNS stimulants for ADHD-related symptoms, forecasting revenues through 2009 gloabally and...
    Cell-Based Diagnostics: Technology, Applications, and Markets

    Published: January 1, 2005 | Price: $3,500.00 – $7,000.00

    This report covers clinical and drug discovery assay systems that use cells as the basic source material. Sources of the cells to be studied include peripheral blood, cord blood, bone marrow, urine, cerebrospinal and other body fluids and tissue samples. Cell analysis is not a new laboratory procedure. Clinical diagnostics using cells and tissues is one of the oldest disciplines in laboratory medicine. Histological study of biopsy samples, the complete blood count, and the enumeration of disease-bearing cells have been...
    Nucleic Acid-Based Therapeutics: World Markets, Developments, and Applications

    Published: January 1, 2005 | Price: $3,500.00 – $7,000.00

    The concept of nucleic acid-based therapeutics is not a new one. For a long time it has been thought that molecules similar to those that make up our genetic structure would make effective therapeutics. It is an idea whose time has come. There are six types of nucleic acid-based therapeutics that have been proposed. Some have made it to market, others are still in development, and some have been put on the back burner due to technical difficulties. The six...
    The U.S. Market for Over-The-Counter Pain Medication

    Published: January 1, 2005 | Price: $3,000.00 – $6,000.00

    The U.S. market for Over-the-Counter (OTC) Pain Medication presents an in-depth analysis of the performance of various analgesics, including non-steroidal anti-inflammatory drugs (NSAID) and topical products in the US market. The analysis captures the performance of the market players, categories and leading brands in terms of revenue growth and volume growth. It also identifies key issues, drivers, challenges, regulations and trends affecting the marketplace. The report provides a comprehensive analysis of the pain medication products that are currently in the...
    U.S. Market for Over-the-Counter Diagnostics: Product Sales and Consumer Survey, The

    Published: November 15, 2004 | Price: $4,995.00 – $9,990.00

    This unprecedented study provides detailed market data on products and segments in the retail OTC diagnostic market in the United States. In addition to market size, growth and competitive share information on each of six testing categories plus testing accessories, the report contains the results of a major consumer survey conducted jointly by Kalorama Information and The Telephone Centre, Inc., focusing on consumer attitudes and awareness of OTC testing products and their marketing channels. This valuable consumer information, never before...
    The World Market For Pain Management Drugs And Devices: Applications And Top Products

    Published: November 1, 2004 | Price: $3,500.00 – $7,000.00

    The market for pain management products is growing at a brisk pace, with some segments moving ahead at over 20%. The future for specialized pharmaceutical and medical device products in this market is bright and new opportunities exist for emerging treatment modalities as well. The report presents the most up-to-date information about the top-producing pain management products in terms of revenues, and analyzes the market by specific pain sites as well. The report concentrates on the following application areas: Burn...
    The World Market for Vaccines

    Published: November 1, 2004 | Price: $3,500.00 – $7,000.00

    This report covers pediatric and adult preventive vaccine products and provides an analysis of therapeutic vaccines for cancer treatment. In assessing the market for vaccine products, Kalorama Information provides sales data for the 2001-2003 historical years, the 2004 base year, and the 2001 through 2010 forecast years. Revenues are expressed in terms of manufacturers’ annual sales and in current U.S. dollars. The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources...
    Cosmetic Surgery Market: Procedure Volumes and Fees for the Top Five Procedures, 2002-2006

    Published: October 1, 2004 | Price: $395.00 – $790.00

    Based on findings from Kalorama Information’s research study Facial Cosmetic Surgery and Rejuvenation Markets: Business, Technologies, and Competitive Intelligence (July 2004), this summary covers the top five surgeries and an “other” category. The top five procedures are: Breast augmentation/reduction Liposuction Rytidectomy (face lifts) Blepharoplasty (eyelid lift) Rhinoplasty (nose job) The analysis includes data on procedures and revenues for surgery but not market data for conventional surgical instruments and equipment. The “other” category includes such procedures as tummy tucks , buttocks...
    Molecular Diagnostics for Inherited Disease Testing: Testing volume, cost per test, and market potential

    Published: October 1, 2004 | Price: $995.00 – $1,990.00

    Gene and chromosome testing for inherited diseases currently represents the third largest molecular diagnostics testing segment in the U.S. Assays in this market address applications in genetic carrier and predisposition testing. Currently, most testing is for prenatal screening and for assessing clinically suspect newborns for various chromosomal abnormalities (e.g., Down’s syndrome, fragile X syndrome). Some testing is used for genetic counseling for couples planning to have children. Such diagnostics test for the presence of carrier states of diseases such as...
    Molecular Diagnostics for Infectious Disease Testing: Testing volume, cost per test, and market potential

    Published: October 1, 2004 | Price: $995.00 – $1,990.00

    Currently, the largest market application segment for molecular diagnostics is that for infectious disease testing. The segment is expected to grow at an annual rate between 7% and 8% over the next few years will present some excellent market opportunites for molecular diagnostic competitors. This summary report, extracted from Kalorama Information’s U.S. Market for Molecular Diagnostics, (2nd Edition, May 2004), focuses on the technologies and application of molecular diagnostics in the field of infectious disease testing. The major market effects...
    Molecular Diagnostics for Pharmacogenetic Testing: Testing volume, cost per test, and market potential

    Published: October 1, 2004 | Price: $995.00 – $1,990.00

    The field of pharmacogenetics promises to open up new opportunities for the diagnostic industry at the same time it opens the door to more effective therapeutics. Pharmacogenetics is based on the principle that the effects of a given medication when administered to a patient are determined, at least in part, by his or her genetic constitution. Differences in drug metabolism may lead to varying adverse events or more pronounced adverse events in different individuals, and differing metabolism may also lead...